The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Valganciclovir-Global Market Insights and Sales Trends 2025
Synopsis
Valganciclovir is an antiviral. It is used to treat infections caused by viruses. This medicine is also used to prevent CMV disease in patients who have received an organ transplant (eg, heart, kidney, or kidney-pancreas transplant).
The global Valganciclovir market size is expected to reach US$ 325.4 million by 2029, growing at a CAGR of 5.8% from 2023 to 2029. The market is mainly driven by the significant applications of Valganciclovir in various end use industries. The expanding demands from the Adults and Children, are propelling Valganciclovir market. Powder, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Tablet segment is estimated at % CAGR for the next seven-year period.
On the basis of region, the valganciclovir market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is expected to dominate the valganciclovir market. This can be attributed to the rising prevalence of Valganciclovir-resistant cytomegalovirus (CMV) and the increasing demand for oral drugs in this region. Latin America is projected to grow at a significant rate during the forecast period owing to the rising prevalence of Valganciclovir-resistant cytomegalovirus (CMV) and the increasing demand for oral drugs in this region.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Valganciclovir, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Valganciclovir market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Valganciclovir market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Valganciclovir sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Valganciclovir covered in this report include Rakshit Drugs, United Biotech Private Limited and Roche, etc.
The global Valganciclovir market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Rakshit Drugs
United Biotech Private Limited
Roche
Global Valganciclovir market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Valganciclovir market, Segment by Type:
Powder
Tablet
Global Valganciclovir market, by Application
Adults
Children
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Valganciclovir manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Valganciclovir in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Valganciclovir is an antiviral. It is used to treat infections caused by viruses. This medicine is also used to prevent CMV disease in patients who have received an organ transplant (eg, heart, kidney, or kidney-pancreas transplant).
The global Valganciclovir market size is expected to reach US$ 325.4 million by 2029, growing at a CAGR of 5.8% from 2023 to 2029. The market is mainly driven by the significant applications of Valganciclovir in various end use industries. The expanding demands from the Adults and Children, are propelling Valganciclovir market. Powder, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Tablet segment is estimated at % CAGR for the next seven-year period.
On the basis of region, the valganciclovir market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is expected to dominate the valganciclovir market. This can be attributed to the rising prevalence of Valganciclovir-resistant cytomegalovirus (CMV) and the increasing demand for oral drugs in this region. Latin America is projected to grow at a significant rate during the forecast period owing to the rising prevalence of Valganciclovir-resistant cytomegalovirus (CMV) and the increasing demand for oral drugs in this region.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Valganciclovir, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Valganciclovir market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Valganciclovir market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Valganciclovir sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Valganciclovir covered in this report include Rakshit Drugs, United Biotech Private Limited and Roche, etc.
The global Valganciclovir market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Rakshit Drugs
United Biotech Private Limited
Roche
Global Valganciclovir market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Valganciclovir market, Segment by Type:
Powder
Tablet
Global Valganciclovir market, by Application
Adults
Children
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Valganciclovir manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Valganciclovir in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Valganciclovir Market Overview
1.1 Valganciclovir Product Overview
1.2 Valganciclovir Market Segment by Type
1.2.1 Powder
1.2.2 Tablet
1.3 Global Valganciclovir Market Size by Type
1.3.1 Global Valganciclovir Market Size Overview by Type (2018-2029)
1.3.2 Global Valganciclovir Historic Market Size Review by Type (2018-2023)
1.3.3 Global Valganciclovir Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Valganciclovir Sales Breakdown by Type (2018-2023)
1.4.2 Europe Valganciclovir Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Valganciclovir Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Valganciclovir Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Valganciclovir Sales Breakdown by Type (2018-2023)
2 Global Valganciclovir Market Competition by Company
2.1 Global Top Players by Valganciclovir Sales (2018-2023)
2.2 Global Top Players by Valganciclovir Revenue (2018-2023)
2.3 Global Top Players by Valganciclovir Price (2018-2023)
2.4 Global Top Manufacturers Valganciclovir Manufacturing Base Distribution, Sales Area, Product Type
2.5 Valganciclovir Market Competitive Situation and Trends
2.5.1 Valganciclovir Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Valganciclovir Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Valganciclovir as of 2022)
2.7 Date of Key Manufacturers Enter into Valganciclovir Market
2.8 Key Manufacturers Valganciclovir Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Valganciclovir Status and Outlook by Region
3.1 Global Valganciclovir Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Valganciclovir Historic Market Size by Region
3.2.1 Global Valganciclovir Sales in Volume by Region (2018-2023)
3.2.2 Global Valganciclovir Sales in Value by Region (2018-2023)
3.2.3 Global Valganciclovir Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Valganciclovir Forecasted Market Size by Region
3.3.1 Global Valganciclovir Sales in Volume by Region (2024-2029)
3.3.2 Global Valganciclovir Sales in Value by Region (2024-2029)
3.3.3 Global Valganciclovir Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Valganciclovir by Application
4.1 Valganciclovir Market Segment by Application
4.1.1 Adults
4.1.2 Children
4.2 Global Valganciclovir Market Size by Application
4.2.1 Global Valganciclovir Market Size Overview by Application (2018-2029)
4.2.2 Global Valganciclovir Historic Market Size Review by Application (2018-2023)
4.2.3 Global Valganciclovir Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Valganciclovir Sales Breakdown by Application (2018-2023)
4.3.2 Europe Valganciclovir Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Valganciclovir Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Valganciclovir Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Valganciclovir Sales Breakdown by Application (2018-2023)
5 North America Valganciclovir by Country
5.1 North America Valganciclovir Historic Market Size by Country
5.1.1 North America Valganciclovir Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Valganciclovir Sales in Volume by Country (2018-2023)
5.1.3 North America Valganciclovir Sales in Value by Country (2018-2023)
5.2 North America Valganciclovir Forecasted Market Size by Country
5.2.1 North America Valganciclovir Sales in Volume by Country (2024-2029)
5.2.2 North America Valganciclovir Sales in Value by Country (2024-2029)
6 Europe Valganciclovir by Country
6.1 Europe Valganciclovir Historic Market Size by Country
6.1.1 Europe Valganciclovir Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Valganciclovir Sales in Volume by Country (2018-2023)
6.1.3 Europe Valganciclovir Sales in Value by Country (2018-2023)
6.2 Europe Valganciclovir Forecasted Market Size by Country
6.2.1 Europe Valganciclovir Sales in Volume by Country (2024-2029)
6.2.2 Europe Valganciclovir Sales in Value by Country (2024-2029)
7 Asia-Pacific Valganciclovir by Region
7.1 Asia-Pacific Valganciclovir Historic Market Size by Region
7.1.1 Asia-Pacific Valganciclovir Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Valganciclovir Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Valganciclovir Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Valganciclovir Forecasted Market Size by Region
7.2.1 Asia-Pacific Valganciclovir Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Valganciclovir Sales in Value by Region (2024-2029)
8 Latin America Valganciclovir by Country
8.1 Latin America Valganciclovir Historic Market Size by Country
8.1.1 Latin America Valganciclovir Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Valganciclovir Sales in Volume by Country (2018-2023)
8.1.3 Latin America Valganciclovir Sales in Value by Country (2018-2023)
8.2 Latin America Valganciclovir Forecasted Market Size by Country
8.2.1 Latin America Valganciclovir Sales in Volume by Country (2024-2029)
8.2.2 Latin America Valganciclovir Sales in Value by Country (2024-2029)
9 Middle East and Africa Valganciclovir by Country
9.1 Middle East and Africa Valganciclovir Historic Market Size by Country
9.1.1 Middle East and Africa Valganciclovir Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Valganciclovir Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Valganciclovir Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Valganciclovir Forecasted Market Size by Country
9.2.1 Middle East and Africa Valganciclovir Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Valganciclovir Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Rakshit Drugs
10.1.1 Rakshit Drugs Company Information
10.1.2 Rakshit Drugs Introduction and Business Overview
10.1.3 Rakshit Drugs Valganciclovir Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Rakshit Drugs Valganciclovir Products Offered
10.1.5 Rakshit Drugs Recent Development
10.2 United Biotech Private Limited
10.2.1 United Biotech Private Limited Company Information
10.2.2 United Biotech Private Limited Introduction and Business Overview
10.2.3 United Biotech Private Limited Valganciclovir Sales, Revenue and Gross Margin (2018-2023)
10.2.4 United Biotech Private Limited Valganciclovir Products Offered
10.2.5 United Biotech Private Limited Recent Development
10.3 Roche
10.3.1 Roche Company Information
10.3.2 Roche Introduction and Business Overview
10.3.3 Roche Valganciclovir Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Roche Valganciclovir Products Offered
10.3.5 Roche Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Valganciclovir Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Valganciclovir Industrial Chain Analysis
11.4 Valganciclovir Market Dynamics
11.4.1 Valganciclovir Industry Trends
11.4.2 Valganciclovir Market Drivers
11.4.3 Valganciclovir Market Challenges
11.4.4 Valganciclovir Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Valganciclovir Distributors
12.3 Valganciclovir Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
